Findings support development of γδ T cells for gastrointestinal diseases GammaDelta Therapeutics Ltd, an emerging biotech company developing novel immunotherapies for cancer and other diseases announced today the publication in Nature Immunology of new data examining the biological role of gamma delta (γδ) T cell receptors. The findings arose from[…]
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run Roundtable at the Early and Managed Access Program Conference in the UK from October 22nd to 24th 2018 Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to[…]
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run Roundtable at the Early and Managed Access Program Conference in the UK from October 22nd to 24th 2018 Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to[…]
Q BioMed Orphan Drug VP, who started the first Expanded Access Program Database asked to Speak on Panels and run Roundtable at the Early and Managed Access Program Conference in the UK from October 22nd to 24th 2018 Q BioMed Inc. (OTCQB: QBIO), a biotechnology acceleration company, is pleased to[…]
Exclusive worldwide licence deal adding to Carrick”s rapid pipeline expansion Preparations for pivotal studies underway Dr. George Golumbeski appointed as Chairman of the Board Carrick Therapeutics, a biopharmaceutical company focusing on the innovative research and development of transformative oncology medicines, has today announced that it has licensed exclusive worldwide rights[…]
The global Bitumen Market is estimated to develop at a substantial CAGR for the duration of the prediction due to growing usage in Adhesives, Waterproofing, Insulation, and Roadways. Speedy expansion in developing marketplaces has contributed to growth in substructure actions. The combination of carbon-based fluids that are black, sticky, solvable[…]
‘The opening of operations for CRB in Germany strategically aligns with our clients” growth in the region over the last decade and allows us to serve their needs locally,’ CRB president, Ryan Schroeder, said. ‘In addition, Germany”s commitment to research and manufacturing in the life science industry makes it a[…]
Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP), reports its researchers have identified a series of small molecule drugs that inhibit NR2F6 and also activate human immune cells ex-vivo. Evidence provided by studies suggest that NR2F6 represses the body”s immune response against tumors; therefore inhibiting NR2F6 may lead to enhanced[…]
Purchase expands Avison Young”s U.K. footprint and adds eight Principals Mark E. Rose, Chair and CEO of Avison Young, the world”s fastest-growing, private and Principal-led, global commercial real estate services firm, announced today that it has acquired market-leading U.K. firm Wilkinson Williams LLP and opened a new office in London”s West End. Since[…]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company”s Chief Scientific Officer, Dr. Alex Stevenson, has spoken at the International Human Microbiome Consortium (IHMC) 2018 on the importance of function in the development of live biotherapeutics. ‘Ahead of World Microbiome[…]
Utilizzando il sito, accetti l'utilizzo dei cookie da parte nostra. maggiori informazioni
Questo sito utilizza i cookie per fornire la migliore esperienza di navigazione possibile. Continuando a utilizzare questo sito senza modificare le impostazioni dei cookie o cliccando su "Accetta" permetti il loro utilizzo.
